Home › Compare › PFSF vs MRK

PFSF vs MRK: Dividend Comparison 2026

PFSF yields 5882.35% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFSF wins by $302684608132120.06M in total portfolio value
10 years
PFSF
PFSF
● Live price
5882.35%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$302684608132120.06M
Annual income
$292,889,908,842,934,530,000.00
Full PFSF calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — PFSF vs MRK

📍 PFSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPFSFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PFSF + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
PFSF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PFSF
Annual income on $10K today (after 15% tax)
$500,000.00/yr
After 10yr DRIP, annual income (after tax)
$248,956,422,516,494,340,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, PFSF beats the other by $248,956,422,516,494,340,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PFSF + MRK for your $10,000?

PFSF: 50%MRK: 50%
100% MRK50/50100% PFSF
Portfolio after 10yr
$151342304066060.03M
Annual income
$146,444,954,421,467,270,000.00/yr
Blended yield
96.76%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PFSF
No analyst data
Altman Z
-57.9
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PFSF buys
0
MRK buys
0
No recent congressional trades found for PFSF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPFSFMRK
Forward yield5882.35% ✓3.25%
Annual dividend / share$2.00$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR0%8.2% ✓
Portfolio after 10y$302684608132120.06M ✓$30.7K
Annual income after 10y$292,889,908,842,934,530,000.00 ✓$950.29
Total dividends collected$302025190529273.63M ✓$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PFSF vs MRK ($10,000, DRIP)

YearPFSF PortfolioPFSF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$598,935$588,235.29$11,192$351.54+$587.7K → PFSF
2$33,567,485$32,926,624.20$12,524$392.70+$33.55M → PFSF
3$1,760,572,584$1,724,655,375.00$14,015$438.65+$1760.56M → PFSF
4$86,422,145,745$84,538,333,079.89$15,682$489.96+$86422.13M → PFSF
5$3,970,768,237,328$3,878,296,541,381.34$17,547$547.23+$3970768.22M → PFSF
6$170,784,185,257,923$166,535,463,243,981.50$19,632$611.16+$170784185.24M → PFSF
7$6,876,898,713,370,412$6,694,159,635,144,434.00$21,963$682.53+$6876898713.35M → PFSF
8$259,275,158,018,476,900$251,916,876,395,170,560.00$24,571$762.18+$259275158018.45M → PFSF
9$9,153,924,569,332,272,000$8,876,500,150,252,502,000.00$27,486$851.08+$9153924569332.24M → PFSF
10$302,684,608,132,120,050,000$292,889,908,842,934,530,000.00$30,745$950.29+$302684608132120.06M → PFSF

PFSF vs MRK: Complete Analysis 2026

PFSF — Stock

Pacific Software, Inc., a development stage company, engages in designing, developing, licensing, and operating transactional solutions worldwide. The company manages BOAPIN.com, a multi-lingual and multi-faceted commodities trading platform designed for international clients, traders, and subscribers. It is also postured for investments, mergers, acquisitions, and business combination strategies for various technologies and digital platforms. The company intends to deliver its trading solutions to agriculture, fertilizers, chemicals, cosmetics, electronics, and equipment industries. The company was formerly known as Pacific Mining, Inc. and changed its name to Pacific Software, Inc. in November 2006. Pacific Software, Inc. was founded in 2005 and is headquartered in Toronto, Canada.

Full PFSF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this PFSF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PFSF vs SCHDPFSF vs JEPIPFSF vs OPFSF vs KOPFSF vs MAINPFSF vs JNJPFSF vs ABBVPFSF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.